By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German firm Caprotec Bioanalytics today announced it has raised €1 million ($1.4 million) in a Series B round.

The second closing brings the total amount raised in the round to €5 million in equity, Caprotec said. The company announced it had raised €4 million in the Series B round last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.